Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents in USD of ON SEMICONDUCTOR CORP from Q4 2015 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
ON SEMICONDUCTOR CORP quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents history and change rate from Q4 2015 to Q3 2025.
  • ON SEMICONDUCTOR CORP Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents for the quarter ending 03 Oct 2025 was $2.47B, a 0.07% increase year-over-year.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, YoY Quarterly Change (%)

ON SEMICONDUCTOR CORP Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $2.47B +$1.6M +0.07% 03 Oct 2025 10-Q 03 Nov 2025
Q2 2025 $2.53B +$297M +13.3% 04 Jul 2025 10-Q 04 Aug 2025
Q1 2025 $2.77B +$149M +5.68% 04 Apr 2025 10-Q 05 May 2025
Q4 2024 $2.69B +$208M +8.39% 31 Dec 2024 10-Q 03 Nov 2025
Q3 2024 $2.47B -$218M -8.12% 27 Sep 2024 10-Q 03 Nov 2025
Q2 2024 $2.23B -$400M -15.2% 28 Jun 2024 10-Q 04 Aug 2025
Q1 2024 $2.62B -$99.9M -3.68% 29 Mar 2024 10-Q 05 May 2025
Q4 2023 $2.49B -$448M -15.3% 31 Dec 2023 10-Q 03 Nov 2025
Q3 2023 $2.69B +$218M +8.83% 29 Sep 2023 10-Q 28 Oct 2024
Q2 2023 $2.63B +$819M +45.1% 30 Jun 2023 10-Q 29 Jul 2024
Q1 2023 $2.72B +$1.05B +62.8% 31 Mar 2023 10-Q 29 Apr 2024
Q4 2022 $2.93B +$1.56B +113% 31 Dec 2022 10-K 10 Feb 2025
Q3 2022 $2.47B +$1.08B +77.8% 30 Sep 2022 10-Q 30 Oct 2023
Q2 2022 $1.81B +$722M +66.1% 01 Jul 2022 10-Q 31 Jul 2023
Q1 2022 $1.67B +$625M +59.9% 01 Apr 2022 10-Q 01 May 2023
Q4 2021 $1.38B +$296M +27.4% 31 Dec 2021 10-K 10 Feb 2025
Q3 2021 $1.39B -$264M -16% 01 Oct 2021 10-Q 31 Oct 2022
Q2 2021 $1.09B -$968M -47% 02 Jul 2021 10-Q 01 Aug 2022
Q1 2021 $1.04B -$938M -47.3% 02 Apr 2021 10-Q 02 May 2022
Q4 2020 $1.08B +$187M +20.9% 31 Dec 2020 10-K 05 Feb 2024
Q3 2020 $1.65B +$726M +78.2% 02 Oct 2020 10-Q 01 Nov 2021
Q2 2020 $2.06B +$1.16B +129% 03 Jul 2020 10-Q 02 Aug 2021
Q1 2020 $1.98B +$1.02B +107% 03 Apr 2020 10-Q 03 May 2021
Q4 2019 $894M -$193M -17.7% 31 Dec 2019 10-K 06 Feb 2023
Q3 2019 $929M -$39.8M -4.11% 27 Sep 2019 10-Q 02 Nov 2020
Q2 2019 $899M +$31.4M +3.62% 28 Jun 2019 10-Q 10 Aug 2020
Q1 2019 $957M +$14.8M +1.57% 29 Mar 2019 10-Q 11 May 2020
Q4 2018 $1.09B +$121M +12.5% 31 Dec 2018 10-K 14 Feb 2022
Q3 2018 $969M +$49.9M +5.43% 28 Sep 2018 10-Q 28 Oct 2019
Q2 2018 $868M -$21.3M -2.4% 29 Jun 2018 10-Q 05 Aug 2019
Q1 2018 $942M +$196M +26.2% 30 Mar 2018 10-Q 29 Apr 2019
Q4 2017 $967M -$79.2M -7.57% 31 Dec 2017 10-K 16 Feb 2021
Q3 2017 $919M 29 Sep 2017 10-Q 29 Oct 2018
Q2 2017 $889M 30 Jun 2017 10-Q 30 Jul 2018
Q1 2017 $747M 31 Mar 2017 10-Q 30 Apr 2018
Q4 2016 $1.05B +$409M +64.1% 31 Dec 2016 10-K 19 Feb 2020
Q4 2015 $637M 31 Dec 2015 10-K 20 Feb 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.